Smiths Medical, Inc. Receives FDA Clearance for Expansion of Power Injectable Port Line Including a New Arm Port

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, part of the global technology business Smiths Group, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the P.A.S. PORT® T2 POWER P.A.C. and PORT-A-CATH® II POWER P.A.C. Dual-lumen Implantable Access Systems. The new products expand the existing port line from seven to ten systems now available for power injections of contrast media.